HIV New Product Introduction Toolkit

In December 2022, 40+ community groups and an additional 45+ individuals released a community position statement calling on the global...

CHAI developed these frequently asked questions (FAQs) to lay out information for communities and PLHIV on the subject of DRV/r (400/50...

CHAI has developed a generic training curriculum that is intended to be adapted for local contexts and their respective training plans.

A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.

CHAI developed these frequently asked questions (FAQs) to lay out information for national HIV programs considering the adoption and...

This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...

The CHAI COST Tool is a model that helps to estimate the financial impact of switching existing second-line (2L) patients to optimized,...